140 related articles for article (PubMed ID: 16390235)
1. Promoter hypermethylation of the p16 gene and loss of its protein expression is correlated with tumor progression in extrahepatic bile duct carcinomas.
Hong SM; Choi J; Ryu K; Ro JY; Yu E
Arch Pathol Lab Med; 2006 Jan; 130(1):33-8. PubMed ID: 16390235
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China.
Huang Q; Ai L; Zhang ZY; Fan CY; Weiss LM
Mod Pathol; 2004 Apr; 17(4):416-22. PubMed ID: 14976529
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung.
Awaya H; Takeshima Y; Amatya VJ; Furonaka O; Tagawa K; Kohno N; Inai K
Pathol Int; 2004 Jul; 54(7):486-9. PubMed ID: 15189501
[TBL] [Abstract][Full Text] [Related]
5. Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis.
Ishikawa A; Sasaki M; Sato Y; Ohira S; Chen MF; Huang SF; Oda K; Nimura Y; Nakanuma Y
Hum Pathol; 2004 Dec; 35(12):1505-14. PubMed ID: 15619210
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
8. Two distinct pathways of p16 gene inactivation in gallbladder cancer.
Tadokoro H; Shigihara T; Ikeda T; Takase M; Suyama M
World J Gastroenterol; 2007 Dec; 13(47):6396-403. PubMed ID: 18081229
[TBL] [Abstract][Full Text] [Related]
9. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
Prall F; Ostwald C; Weirich V; Nizze H
Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
[TBL] [Abstract][Full Text] [Related]
10. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas.
Sterlacci W; Tzankov A; Veits L; Zelger B; Bihl MP; Foerster A; Augustin F; Fiegl M; Savic S
J Thorac Oncol; 2011 Oct; 6(10):1649-57. PubMed ID: 21857254
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
[TBL] [Abstract][Full Text] [Related]
15. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
